U.S. Ciena, Huntsman, Prog Holdings
June 7 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ciena, Huntsman and Prog Holdings, on Friday.
HIGHLIGHTS
* Capital One Financial Corp COF.N: BTIG initiates coverage with neutral rating |
* Ciena Corp CIEN.N: Raymond James cuts to outperform from strong buy |
* Collegium Pharmaceutical Inc COLL.O: Jefferies raises to buy from hold |
* Huntsman Corp HUN.N: JP Morgan raises to overweight from underweight |
* Prog Holdings Inc PRG.N: BTIG initiates coverage with neutral rating |
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.
* 2Seventy Bio Inc TSVT.O: Goldman Sachs cuts target price to $2 from $5 |
* 3M Co MMM.N: BofA Global Research raises price objective to $120 from $105 |
* 3M Co MMM.N: BofA Global Research raises to buy from neutral |
* Aaron's Company Inc AAN.N: BTIG initiates coverage with neutral rating |
* Abm Industries Inc ABM.N: Deutsche Bank raises target price to $53 from $49 |
* Abm Industries Inc ABM.N: Truist Securities raises target price to $49 from $45 |
* Abm Industries Inc ABM.N: UBS raises target price to $51 from $45 |
* Acco Brands Corp ACCO.N: Barrington Research cuts target price to $7 from $7.5 |
* Addus Homecare Corp ADUS.O: Oppenheimer raises target price to $130 from $118 |
* Adobe Inc ADBE.O: Mizuho cuts target price to $640 from $680 |
* Adobe Inc ADBE.O: Stifel cuts target price to $600 from $625 |
* Affirm Holdings Inc AFRM.O: BTIG assumes coverage with neutral rating |
* Ally Financial Inc ALLY.N: BTIG initiates coverage with buy rating; price target $51 |
* American Express Co AXP.N: BTIG initiates coverage with neutral rating |
* America's Car-Mart Inc CRMT.O: BTIG initiates coverage with neutral rating |
* Annaly Capital Management Inc NLY.N: UBS raises target price to $20.5 from $19.5 |
* Armour Residential REIT Inc ARR.N: UBS raises target price to $19 from $18 |
* Atlanticus Holdings Corp ATLC.O: BTIG initiates coverage with buy rating; PT $45 |
* Avenue Therapeutics Inc ATXI.O: Maxim Group cuts PT to $12 from $56.25 to reflect 1-for-75 reverse stock split |
* Avery Dennison Corp AVY.N: Baird raises target price to $250 from $230 |
* Banzai International Inc BNZI.O: Ascendiant Capital Markets raises PT to $3.25 from $3 |
* Big Lots Inc BIG.N: Telsey Advisory Group cuts target price to $2.5 from $5 |
* Biomea Fusion Inc BMEA.O: Citigroup cuts target price to $45 from $90 |
* Biomea Fusion Inc BMEA.O: H.C. Wainwright cuts target price to $15 from $50 |
* Biomea Fusion Inc BMEA.O: Scotiabank cuts target price to $21 from $41 |
* Boeing BA.N: UBS cuts target price to $240 from $250 |
* Braze Inc BRZE.O: JP Morgan cuts target price to $55 from $58 |
* Braze Inc BRZE.O: Raymond James cuts target price to $55 from $65 |
* Bread Financial Holdings Inc BFH.N: BTIG initiates coverage with neutral rating |
* Brown-Forman Corp BFb.N: TD Cowen cuts target price to $50 from $65 |
* Campbell Soup Co CPB.N: Stephens raises target price to $51 from $50 |
* Capital One Financial Corp COF.N: BTIG initiates coverage with neutral rating |
* Chargepoint Holdings Inc CHPT.N: UBS cuts target price to $2 from $2.25 |
* Charles River Laboratories International Inc CRL.N: Mizuho initiates with $235 PT |
* Charles River Laboratories International Inc CRL.N: Mizuho initiates with neutral rating |
* Chemours Co CC.N: Mizuho initiates with neutral rating and $25 PT |
* Ciena Corp CIEN.N: Northland Capital raises target price to $46 |
* Ciena Corp CIEN.N: Raymond James cuts target price to $54 from $59 |
* Ciena Corp CIEN.N: Raymond James cuts to outperform from strong buy |
* Collegium Pharmaceutical Inc COLL.O: Jefferies raises target price to $44 from $41 |
* Collegium Pharmaceutical Inc COLL.O: Jefferies raises to buy from hold |
* Comscore Inc SCOR.O: Needham cuts target price to $17 from $25 |
* Concrete Pumping Holdings Inc BBCP.O: Stifel cuts target price to $8 from $9 |
* Couchbase Inc BASE.O: Goldman Sachs cuts target price to $18 from $30 |
* Couchbase Inc BASE.O: Goldman Sachs cuts to sell from neutral |
* Discover Financial Services DFS.N: BTIG initiates coverage with neutral rating |
* Docusign Inc DOCU.O: BofA Global Research cuts price objective to $60 from $72 |
* Docusign Inc DOCU.O: Morgan Stanley cuts target price to $62.00 from $65.00 |
* Docusign Inc DOCU.O: RBC cuts target price to $52 from $59 |
* Docusign Inc DOCU.O: UBS cuts target price to $56 from $62 |
* Dollar Tree Inc DLTR.O: Citigroup cuts to neutral from buy; cuts PT to $120 from $163 |
* Dollar Tree Inc DLTR.O: Deutsche Bank cuts target price to $149 from $151 |
* Duckhorn Portfolio Inc NAPA.N: BMO cuts target price to $9 from $10 |
* Duckhorn Portfolio Inc NAPA.N: Citigroup cuts target price to $10 from $11 |
* Duos Technologies Group Inc DUOT.O: Ascendiant Capital Markets cuts PT to $5.75 from $6 |
* Eli Lilly LLY.N: Jefferies raises target price to $957 from $925 |
* Emerson EMR.N: HSBC raises target price to $132 from $114 |
* Endra Life Sciences Inc NDRA.O: Ascendiant Capital Markets cuts target to $8 from $10 |
* Exxon Mobil XOM.N: Truist Securities cuts target price to $124 from $146 |
* Exxon Mobil XOM.N: Truist Securities cuts to hold from buy |
* Firstcash Holdings Inc FCFS.O: BTIG initiates coverage with neutral rating |
* Five Below Inc FIVE.O: Deutsche Bank cuts target price to $155 from $177 |
* Ftai Aviation Ltd FTAI.O: Deutsche Bank raises target price to $100 from $90 |
* Ftai Aviation Ltd FTAI.O: RBC raises target price to $95 from $85 |
* Gen Digital Inc GEN.O: Morgan Stanley cuts target price to $27.00 from $28.00 |
* Gen Digital Inc GEN.O: Morgan Stanley cuts to equal-weight from overweight |
* Geron Corp GERN.O: Needham raises target price to $6 from $5 |
* Greif Inc GEF.N: Wells Fargo raises target price to $80 from $78 |
* Halozyme Therapeutics Inc HALO.O: Leerink Partners raises target price to $53 from $45 |
* Halozyme Therapeutics Inc HALO.O: TD Cowen raises target price to $59 from $54 |
* HCA Healthcare Inc HCA.N: Jefferies raises target price to $390 from $350 |
* Healthequity Inc HQY.O: Raymond James raises target price to $105 from $100 |
* Herc Holdings Inc HRI.N: JP Morgan initiates coverage with neutral rating; PT $155 |
* Huntsman Corp HUN.N: JP Morgan raises target price to $27 from $22 |
* Huntsman Corp HUN.N: JP Morgan raises to overweight from underweight |
* Insmed Inc INSM.O: Mizuho raises target price to $82 from $36 |
* International Flavors & Fragrances IFF.N: Oppenheimer initiates coverage with outperform rating |
* International Flavors & Fragrances IFF.N: Oppenheimer initiates coverage with PT $116 |
* Invesco Mortgage Capital Inc IVR.N: UBS raises target price to $9 from $8.5 |
* J M Smucker Co SJM.N: Citigroup raises target price to $139 from $137 |
* J M Smucker Co SJM.N: JP Morgan raises target price to $122 from $120 |
* J M Smucker Co SJM.N: TD Cowen cuts target price to $135 from $140 |
* Kla Corp KLAC.O: Raymond James raises target price to $875 from $750 |
* Korn Ferry KFY.N: UBS raises target price to $68 from $66 |
* Lam Research Corp LRCX.O: Berenberg raises target price to $1150 from $960 |
* Lam Research Corp LRCX.O: Raymond James raises target price to $1,060 from $950 |
* Legalzoom.Com Inc LZ.O: JP Morgan cuts target price to $14 from $15 |
* Lendingclub Corp LC.N: BTIG initiates coverage with buy rating; price target $12 |
* Lyft Inc LYFT.O: BMO raises target price to $19 from $18 |
* Lyft Inc LYFT.O: BofA Global Research raises price objective to $20 from $15 |
* Lyft Inc LYFT.O: BofA Global Research raises to buy from underperform |
* Lyft Inc LYFT.O: Goldman Sachs raises target price to $21 from $19 |
* Lyft Inc LYFT.O: Morgan Stanley raises target price to $18 from $17 |
* Lyft Inc LYFT.O: TD Cowen raises target price to $18 from $16 |
* Lyft Inc LYFT.O: Wedbush raises target price to $19 from $18 |
* Microsoft MSFT.O: Oppenheimer raises target price to $500 from $450 |
* Moderna MRNA.O: Jefferies raises target price to $180 from $155 |
* Nio Inc NIO.N: JP Morgan cuts target price to $5.3 from $5.4 |
* Northrop Grumman NOC.N: Jefferies cuts target price to $500 from $530 |
* ON Holding AG ONON.N: Telsey Advisory Group raises target price to $47 from $40 |
* Onemain Holdings Inc OMF.N: BTIG initiates coverage with neutral rating |
* Open Lending Corp LPRO.O: BTIG assumes coverage with neutral rating |
* Pediatrix Medical Group Inc MD.N: Deutsche Bank raises to hold from sell |
* Planet Labs, Inc. PL.N: Craig-Hallum cuts target price to $2 from $3 |
* Powerschool Holdings Inc PWSC.N: Needham cuts to hold from buy |
* Prog Holdings Inc PRG.N: BTIG initiates coverage with neutral rating |
* PVH Corp PVH.N: TD Cowen raises target price to $154 from $153 |
* Relay Therapeutics Inc RLAY.O: Leerink Partners raises target price to $19 from $18 |
* Rent the Runway Inc RENT.O: Jefferies raises target price to $34 from $21 |
* Replimune Group Inc REPL.O: H.C. Wainwright raises target price to $17 from $12 |
* Samsara Inc IOT.N: Evercore ISI cuts target price to $40 from $41 |
* Samsara Inc IOT.N: Truist Securities cuts target price to $35 from $38 |
* Seres Therapeutics Inc MCRB.O: Chardan Capital Markets cuts target to $1.25 from $6 |
* Seres Therapeutics Inc MCRB.O: Oppenheimer cuts to perform from outperform |
* Skechers USA Inc SKX.N: BofA Global Research raises price objective to $87 from $71 |
* Skechers USA Inc SKX.N: BofA Global Research raises to buy from neutral |
* Sofi Technologies Inc SOFI.O: BTIG assumes coverage with neutral rating |
* Structure Therapeutics Inc GPCR.O: BMO raises target price to $100 from $83 |
* Sunoco LP SUN.N: Stifel raises to buy from hold |
* Sweetgreen Inc SG.N: RBC raises target price to $45 from $35 |
* Synchrony Financial SYF.N: BTIG initiates coverage with buy rating; price target $60 |
* Take-Two Interactive Software Inc TTWO.O: Deutsche Bank raises PT to $190 from $180 |
* Targa Resources Corp TRGP.N: JP Morgan raises target price to $140 from $130 |
* Texas Roadhouse Inc TXRH.O: RBC raises target price to $175 from $165 |
* Third Harmonic Bio Inc THRD.O: Raymond James initiates coverage with outperform rating |
* Third Harmonic Bio Inc THRD.O: Raymond James initiates coverage with target price $18 |
* Tillys Inc TLYS.N: Roth MKM cuts target price to $6 from $7.5 |
* Toro Co TTC.N: D.A. Davidson raises target price to $103 from $95 |
* Toro Co TTC.N: Northland Capital raises target price to $100 from $95 |
* Transdigm Group Inc TDG.N: Jefferies raises PT to $1,625 from $1,520 |
* Transmedics Group Inc TMDX.O: TD Cowen raises target price to $175 from $130 |
* Tronox Holdings Plc TROX.N: Mizuho initiates with neutral rating and $22 price target |
* Two Harbors Investment Corp TWO.N: UBS raises target price to $14.5 from $13.5 |
* Two Harbors Investment Corp TWO.N: UBS raises to buy from neutral |
* Ultragenyx Pharmaceutical Inc RARE.O: Goldman Sachs raises target price to $67 from $56 |
* United Natural Foods Inc UNFI.N: Jefferies raises target price to $14 from $13.5 |
* United Rentals Inc URI.N: JP Morgan initiates coverage with overweight rating; PT $780 |
* Upbound Group Inc UPBD.O: BTIG initiates coverage with buy rating; price target $45 |
* Upstart Holdings Inc UPST.O: BTIG assumes coverage with sell rating; price target $14 |
* Vail Resorts Inc MTN.N: BofA Global Research cuts price objective to $195 from $230 |
* Vail Resorts Inc MTN.N: Deutsche Bank cuts target price to $218 from $226 |
* Vail Resorts Inc MTN.N: Jefferies cuts target price to $190 from $225 |
* Vail Resorts Inc MTN.N: JP Morgan cuts target price to $176 from $217 |
* Vail Resorts Inc MTN.N: JP Morgan cuts to underweight from neutral |
* Vail Resorts Inc MTN.N: Mizuho cuts target price to $231 from $256 |
* Vail Resorts Inc MTN.N: Morgan Stanley cuts target price to $179.00 from $229.00 |
* Vail Resorts Inc MTN.N: Stifel cuts target price to $259 from $262 |
* Vail Resorts Inc MTN.N: Truist Securities cuts target price to $250 from $265 |
* Veeco Instruments Inc VECO.O: Northland Capital raises target price to $53 |
* Victoria's Secret & Co VSCO.N: Barclays raises target price to $19 from $16 |
* Victoria's Secret & Co VSCO.N: Telsey Advisory Group raises PT to $24 from $20 |
* Wynn Resorts Ltd WYNN.O: UBS raises target price to $114 from $105 |
* Zumiez Inc ZUMZ.O: Jefferies raises target price to $19 from $14 |
(Compiled by Bengaluru Newsroom)
</body></html>Похожие активы
Последние новости
Правовая оговорка: Компании группы XM Group предоставляют только услуги по исполнению сделок и доступ к нашей торговой онлайн-среде, в которой пользователи могут просматривать и (или) пользоваться материалами, доступными на вебсайте либо доступными по ссылкам с данного сайта на другие. Предоставление доступа к онлайн-среде не меняет сути предоставляемых услуг и не расширяет их. Такой доступ и пользование материалами предоставляются с учетом:(i) «Условий и положений»; (ii) «Предупреждений о рисках» и (iii) полного текста «Правовой оговорки». Следовательно, подобные материалы предоставляются лишь в качестве информации общего характера. В частности, просим Вас иметь в виду, что материалы, содержащиеся в нашей торговой онлайн-среде, не являются ни просьбой осуществить какие-либо транзакции на финансовых рынках, ни предложением к осуществлению подобных транзакций. Торговля на любом финансовом рынке подразумевает большой риск потери Вашего капитала.
Все материалы, опубликованные в нашей торговой среде, предоставляются только в образовательных или информационных целях и не содержат (и не должны рассматриваться как содержащие) финансовых, инвестиционных или торговых рекомендаций, а также информации о стоимости наших услуг по предоставлению доступа к рынкам, либо предложения или содействия в проведении транзакций по какому-либо финансовому инструменту или по незапрашиваемым финансовым услугам по отношению к Вам.
Любые материалы на данном вебсайте, созданные третьими лицами, а также материалы, подготовленные XM, такие как мнения экспертов, новости, исследования, анализ, котировки и другая информация, а также ссылки на сторонние сайты предоставляются в виде «как есть», как рыночная информация общего характера, и не являют собой рекомендации по инвестициям. Принимая во внимание то, что любые материалы рассматриваются как инвестиционное исследование, Вам следует учесть и принять тот факт, что никакие материалы не подготавливались и не предназначались к использованию в соответствии с правовыми нормами, способствующими независимости инвестиционных исследований. Следовательно, материалы следует рассматривать как материалы рекламного характера согласно соответствующим законам и правовым нормам. Рекомендуем Вам прочесть и уяснить для себя положения наших «Уведомления о субъективном инвестиционном исследовании» и «Предупреждения о рисках» в отношении приведённой выше информации. С этими документами можно ознакомиться здесь.
